Several Federal Reserve officials favored an interest-rate hike last month and many indicated that policy tightening would be necessary if inflation didn't decline, a record of the central bank's most recent policy debate showed. The next Fed decision comes in September. Bloomberg's Michael McKee reports.
Daniel Fried, former US ambassador to Poland, said 'Iranians have little incentive in the near term' to allow the Strait of Hormuz to open and that a solution to the conflict will require patience. Fried, who also served as the assistant Secretary of State for Europe, also said that when it comes to assisting Ukraine in war against Russia, the US is leaving 'perfectly good leverage on the table' because Ukrainian success also means success for the US.
Fuse has raised $100 million to accelerate development and commercialization of its fusion technology. CEO JC Btaiche joins Bloomberg to discuss why the company is focused on building generators faster, and why he sees private companies as critical to helping the US compete with China in the race for fusion energy. He joins Ed Ludlow on "Bloomberg Tech."
Could the AI boom become a new source of inflation for the UK? KPMG UK Chief Economist Yael Selfin discusses how rising chip and AI model costs are filtering through the economy and why higher household energy costs remain a much bigger concern for the Bank of England. She joins Ed Ludlow to discuss on "Bloomberg Tech."
Anthropic's revolving credit facility is anticipated to rise above its approximately $10 billion target, according to sources. That's a substantial increase over a $2.5 billion five-year facility the AI company secured last year, though discussions are still ongoing. Bloomberg's Sridhar Natarajan joins Ed Ludlow with the details on "Bloomberg Tech."
President Donald Trump declared on Wednesday that the US has reached an agreement with Canada on trade, saying that Canadian representatives "gave us the points we had to have." Trump spoke with Bloomberg's Tyler Kendall at the White House.
Matthew McClure, Goldman Sachs global co-head of investment, says the IPO market is "open for business," with AI-related companies accounting for more than half of capital raised despite representing about 20% of IPOs this year. Speaking with Dani Burger on "Bloomberg Deals," McClure says confidence is growing in private equity, with $1.5 trillion of capital waiting to be deployed.
Wall Street staged a rebound after the Treasury said it plans to boost buybacks of longer-dated bonds, a signal the US wants to lower borrowing costs after yields hit multi-decade highs. Lindsay Rosner, Head of Multi-Sector Investing at Goldman Sachs Asset Management, discusses her views on market resilience and global risk premiums.
A personalized vaccine developed by Moderna Inc. and Merck & Co. reduced the recurrence of melanoma in a large, late-stage trial, raising expectations for treating the deadliest form of skin cancer and showing the promise of the embattled mRNA technology. Bloomberg's Sam Fazeli joins to discuss.
Harvard Management Co. disclosed a $2.2 billion stake in SpaceX, showing how the university's endowment has profited from an early bet on Elon Musk's giant rocket company. Janet Lorin, Bloomberg News Higher Education Reporter, discusses the disclosure and what it signals for other university investments.
US Treasury Secretary Scott Bessent made a fresh attempt to rein-in long-term borrowing costs from multi-year highs, sending Treasury yields and the dollar down. Ira Jersey, Chief US Interest Rates Strategist for Bloomberg Intelligence, discusses the move.
On this episode of Stock Movers: - Shares of Moderna (MRNA) surged by a record 101% - the stock's biggest intraday gain on record - after the biotech said a personalized cancer vaccine combined with partner Merck & Co.'s Keytruda helped cut the recurrence of melanoma in a large, late-stage trial. The study also met a key secondary goal of showing the shot could help prevent tumors from spreading to new areas of the body, the companies said in a statement Wednesday. - Shares of Estee Lauder (EL) rallied after the beauty company's adjusted earnings per share and sales metrics topped consensus expectations for the fourth quarter. The midpoint of fiscal 2027 organic sales and adjusted EPS guidance ranges are above Street views. - Shares of La-Z-Boy (LZB) tumbled at the open after the furniture maker's forecast sales for the second quarter missed the average analyst estimate.
